Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Visual Inspection During Packing – V 2.0

Posted on By

SOP for Visual Inspection During Packing – V 2.0

Procedure for Visual Inspection During Packing

Department Packaging/Quality Assurance (QA)/Production
SOP No. SOP/Ointment/098
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for conducting visual inspection during the packaging of ointments. This ensures product integrity, defect-free packaging, and compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel in the Packaging, Quality Assurance (QA), and Production departments responsible for visual inspection of packaging components and final packed products.

3. Responsibilities

  • Packaging Operator: Conducts visual inspection of packaging materials and final packed products.
  • Packaging Supervisor: Monitors the inspection process and ensures defective units are removed.
  • Quality Assurance (QA) Officer: Verifies inspection records and ensures compliance.
  • QA Manager: Approves the final inspected batch before distribution.
See also  Ointments: SOP for Requalification of Key Equipment - V 2.0

4. Accountability

The QA and Packaging Managers are accountable for ensuring that all packaged products undergo thorough visual inspection before batch release.

5. Procedure

5.1 Pre-Inspection Preparations

  • Ensure that the packaging area is clean and free from contaminants.
  • Confirm that proper lighting conditions are available for visual inspection.
  • Verify that only trained personnel perform visual inspection tasks.

5.2 Visual Inspection Parameters

  • Check packaging materials (cartons, tubes, labels) for any visible defects.
  • Inspect printed batch numbers, expiry dates, and
barcodes for accuracy.
  • Ensure that sealing and tamper-evident features are intact.
  • Look for signs of leakage, dents, misalignment, or incorrect labeling.
  • 5.3 Defect Classification

    • Critical Defects: Issues that affect product safety or compliance (e.g., missing labels, incorrect expiry date).
    • Major Defects: Issues that affect usability but not safety (e.g., smudged print, minor carton damage).
    • Minor Defects: Cosmetic issues that do not affect function (e.g., minor label misalignment).

    5.4 Handling of Defective Units

    • Segregate defective units and document reasons for rejection.
    • Investigate the cause of defects and take corrective actions.
    • Dispose of or rework defective units as per QA decision.

    5.5 Documentation and Approval

    • Record visual inspection details in the Inspection Log.
    • QA must review and approve the inspected batch before release.
    • Ensure traceability of inspected batches for regulatory compliance.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • BPR – Batch Packaging Record

    7. Documents

    • Visual Inspection Log (Annexure-1)
    • Final Inspection Approval Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • ICH Q10 – Pharmaceutical Quality System
    • USP <41> – Weights and Balances

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Visual Inspection Log

    Date Batch Number Inspection Parameter Inspected By Result Remarks
    01/02/2025 OINT-101 Label Accuracy QA Officer Pass Compliant
    01/02/2025 OINT-102 Seal Integrity QA Officer Pass Compliant

    Annexure-2: Final Inspection Approval Report

    Date Batch Number Inspection Component Verified By Approval Status
    01/02/2025 OINT-101 Cartons, Labels, Tubes QA Manager Approved
    02/02/2025 OINT-102 Seals, Barcode QA Manager Approved

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Aerosol: SOP for Continuous Agitation of Suspension Formulations – V 2.0
    Next Post: SOP for Sampling of Solvents and Flammable Raw Materials in Quarantine – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version